CETSA quantitatively verifies in vivo target engagement of novel RIPK1 inhibitors in various biospecimens

Tsuyoshi Ishii(Takeda (Japan)), Tomohiro Kawamoto(Takeda (Japan))
Scientific Reports
October 5, 2017
Cited by 49


Related Papers